Investigators
Study information
- Research Area: This is a nationwide study that will concern people screened for HBV and HCV in all Rwandan Health Facilities
- Research type: We will include data for all individuals who received HCV services from screening to treatment and cure [sustained virological response at week 12 (SVR12)], from July 2019 to June 2020.
- Start date: Jul 27, 2021
- End date: Nov 30, 2021
Study aim of the objectives
To assess the impact of the covid-19 pandemic on the HBV and HCV care cascade in Rwanda among people screened during hepatitis screening campaign from 2018 to 2020 in Rwanda
Study setting/Area (Location)
Countrywide
Implementing institution
Rwanda Biomedical Center
Department/Division
IHDPC/HIV, STIs and Viral Hepatitis Division
Impact on Policy
Impact of COVID-19 on HCV program to inform guidelines